Development of a Novel Vaccine Candidates against Cardiobacterium valvarum through Reverse Vaccinology and Computational Approaches

Table 2

T-cells epitopes and percentile score.

MHC-I	Percentile score	MHC-II	Percentile score
RSIEGQVDRF	0.09	DNRRSIEGQVDRF	17
DNRRSIEGQV	12	DNRRSIEGQVDRF	17
RPTADNRRSI	0.04	RPTADNRRSIEGQV	44
NRRSIEGQV	9.8	RPTADNRRSIEGQV	44
RSIEGQVDRF	0.09	RSIEGQVDRFGKVR	26
QVDRFGKVR	1.4	RSIEGQVDRFGKVR	26
TYLGASWNR	0.03	STYLGASWNRSTYH	6.1
ASWNRSTYH	0.63	STYLGASWNRSTYH	6.1
DVKGRDLRL	0.08	DVKGRDLRLPRSTYL	9.2
DLRLPRSTYL	0.12	DVKGRDLRLPRSTYL	9.2
KLNSALEYK	0.02	NWKLNSALEYK	0.29
NWKLNSALEY	1.2	NWKLNSALEYK	0.29
HQFNDNWKL	0.06	DHQFNDNWKLNSAL	9.8
DNWKLNSAL	1.5	DHQFNDNWKLNSAL	9.8
NVSASGTVS	10	YVPQRSNVSASGTVS	5.2
DWNALPEEV	1.7	QPADWNALPEEV	1.4
QPADWNALP	4.1	QPADWNALPEEV	1.4
IFRWQGTEI	1.4	YNIFRWQGTEIAQP	4.2
WQGTEIAQP	11	YNIFRWQGTEIAQP	4.2
WHGKKIAGE	31	WHGKKIAGE	21
KFDNTWHGK	1.1	REKFDNTWHGKKIA	27
NTWHGKKIA	2.5	REKFDNTWHGKKIA	27
HQHLSWMSK	0.05	HQHLSWMSKPDSK	11
LSWMSKPDSK	0.85	SWMSKPDSKYGKGRL	48
WMSKPDSKY	0.08
DSKYGKGRL	2.6	SWMSKPDSKYGKGRL	48
HQHLSWMSK	0.05	WQQHQHLSWMSKPDS	20
WQQHQHLSW	0.59	WQQHQHLSWMSKPDS	20
LSWMSKPDS	21	FKYSGDYLDINGKTL	11
YLDINGKTL	0.14
FKYSGDYLDI	3.1	FKYSGDYLDINGKTL	11